LHP 852
Alternative Names: COR-852; LHP-852Latest Information Update: 31 Jan 2023
At a glance
- Originator Cortexyme
- Developer Quince Therapeutics
- Class Small molecules
- Mechanism of Action Cysteine endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Periodontal disorders